Skip to main content

Ikarian Capital, LLC

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1778253 DALLAS, TX

Position in PRAX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$23,062,682
-$2,456,201 QoQ
Shares Held
71,581
-17.3% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
3.23%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
8 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PRAX Over Time

Shares Held

Position Value (USD)

Derivatives in PRAX

reported options exposure · as of Sep 30, 2025
CallValue
$5,300,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Ikarian Capital, LLC holds $657,306,791 across 105 Biotechnology names. PRAX ranks #5 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 PRAX
Praxis Precision Medicines, Inc.
This page
71,581 $23,062,682

All Filings in PRAX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $23,062,682 71,581
2025-12-31 $25,518,883 86,581
2025-09-30 $5,300,000 100,000
2025-09-30 $1,514,263 28,571
2025-06-30 $10,192,920 242,400
2025-06-30 $11,645,747 276,950
2025-03-31 $5,510,160 145,502
2024-06-30 $174,746 4,225
2024-06-30 $124,080 3,000
2024-03-31 $1,330,236 21,800
2024-03-31 $10,275,035 168,388
2023-12-31 $4,456,000 200,000